vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and FIRST COMMONWEALTH FINANCIAL CORP (FCF). Click either name above to swap in a different company.

FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $121.8M, roughly 1.1× Core Laboratories Inc.). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 4.2%, a 23.9% gap on every dollar of revenue. On growth, FIRST COMMONWEALTH FINANCIAL CORP posted the faster year-over-year revenue change (13.0% vs -1.4%). Over the past eight quarters, FIRST COMMONWEALTH FINANCIAL CORP's revenue compounded faster (5.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.

CLB vs FCF — Head-to-Head

Bigger by revenue
FCF
FCF
1.1× larger
FCF
$133.7M
$121.8M
CLB
Growing faster (revenue YoY)
FCF
FCF
+14.4% gap
FCF
13.0%
-1.4%
CLB
Higher net margin
FCF
FCF
23.9% more per $
FCF
28.1%
4.2%
CLB
Faster 2-yr revenue CAGR
FCF
FCF
Annualised
FCF
5.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
FCF
FCF
Revenue
$121.8M
$133.7M
Net Profit
$5.1M
$37.5M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
28.1%
Revenue YoY
-1.4%
13.0%
Net Profit YoY
14.8%
EPS (diluted)
$0.11
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
FCF
FCF
Q1 26
$121.8M
$133.7M
Q4 25
$138.3M
$137.9M
Q3 25
$134.5M
$136.0M
Q2 25
$130.2M
$131.0M
Q1 25
$123.6M
$118.0M
Q4 24
$129.2M
$120.4M
Q3 24
$134.4M
$121.2M
Q2 24
$130.6M
$120.2M
Net Profit
CLB
CLB
FCF
FCF
Q1 26
$5.1M
$37.5M
Q4 25
$4.9M
$44.9M
Q3 25
$14.2M
$41.3M
Q2 25
$10.6M
$33.4M
Q1 25
$-154.0K
$32.7M
Q4 24
$7.4M
$35.8M
Q3 24
$11.7M
$32.1M
Q2 24
$9.0M
$37.1M
Gross Margin
CLB
CLB
FCF
FCF
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
FCF
FCF
Q1 26
1.5%
Q4 25
11.5%
40.9%
Q3 25
15.6%
38.1%
Q2 25
11.7%
32.1%
Q1 25
3.6%
34.8%
Q4 24
11.0%
37.1%
Q3 24
14.7%
33.4%
Q2 24
12.3%
38.7%
Net Margin
CLB
CLB
FCF
FCF
Q1 26
4.2%
28.1%
Q4 25
3.6%
32.5%
Q3 25
10.6%
30.4%
Q2 25
8.2%
25.5%
Q1 25
-0.1%
27.7%
Q4 24
5.7%
29.8%
Q3 24
8.7%
26.5%
Q2 24
6.9%
30.9%
EPS (diluted)
CLB
CLB
FCF
FCF
Q1 26
$0.11
$0.37
Q4 25
$0.11
$0.44
Q3 25
$0.30
$0.39
Q2 25
$0.22
$0.32
Q1 25
$0.00
$0.32
Q4 24
$0.15
$0.35
Q3 24
$0.25
$0.31
Q2 24
$0.19
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
FCF
FCF
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
$154.9M
Stockholders' EquityBook value
$275.1M
$1.6B
Total Assets
$587.7M
$12.3B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
FCF
FCF
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
FCF
FCF
Q1 26
$154.9M
Q4 25
$110.3M
$261.7M
Q3 25
$114.1M
$262.1M
Q2 25
$124.6M
$262.4M
Q1 25
$124.4M
$262.7M
Q4 24
$126.1M
$263.0M
Q3 24
$139.9M
$136.3M
Q2 24
$147.6M
$136.6M
Stockholders' Equity
CLB
CLB
FCF
FCF
Q1 26
$275.1M
$1.6B
Q4 25
$266.0M
$1.6B
Q3 25
$271.3M
$1.5B
Q2 25
$261.3M
$1.5B
Q1 25
$253.4M
$1.4B
Q4 24
$246.6M
$1.4B
Q3 24
$250.7M
$1.4B
Q2 24
$240.3M
$1.4B
Total Assets
CLB
CLB
FCF
FCF
Q1 26
$587.7M
$12.3B
Q4 25
$584.0M
$12.3B
Q3 25
$591.4M
$12.3B
Q2 25
$602.1M
$12.2B
Q1 25
$591.5M
$11.8B
Q4 24
$585.1M
$11.6B
Q3 24
$600.5M
$12.0B
Q2 24
$597.8M
$11.6B
Debt / Equity
CLB
CLB
FCF
FCF
Q1 26
0.10×
Q4 25
0.41×
0.17×
Q3 25
0.42×
0.17×
Q2 25
0.48×
0.17×
Q1 25
0.49×
0.18×
Q4 24
0.51×
0.19×
Q3 24
0.56×
0.10×
Q2 24
0.61×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
FCF
FCF
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
FCF
FCF
Q1 26
$4.0M
Q4 25
$7.9M
$187.5M
Q3 25
$8.5M
$49.5M
Q2 25
$13.9M
$30.4M
Q1 25
$6.7M
$55.9M
Q4 24
$20.6M
$129.5M
Q3 24
$13.1M
$53.6M
Q2 24
$17.1M
$22.7M
Free Cash Flow
CLB
CLB
FCF
FCF
Q1 26
$517.0K
Q4 25
$5.0M
$171.5M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
$113.9M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
FCF
FCF
Q1 26
0.4%
Q4 25
3.6%
124.3%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
94.6%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
FCF
FCF
Q1 26
Q4 25
2.1%
11.7%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
12.9%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
FCF
FCF
Q1 26
0.77×
Q4 25
1.61×
4.18×
Q3 25
0.60×
1.20×
Q2 25
1.31×
0.91×
Q1 25
1.71×
Q4 24
2.78×
3.61×
Q3 24
1.12×
1.67×
Q2 24
1.90×
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons